Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 45

Related Articles by Review for PubMed (Select 20082923)

2.

Atorvastatin efficacy in the primary and secondary prevention of cardiovascular events.

Arca M, Gaspardone A.

Drugs. 2007;67 Suppl 1:29-42. Review.

PMID:
17910519
4.

Intensive statin therapy in acute coronary syndromes: clinical benefits and vascular biology.

Ray KK, Cannon CP.

Curr Opin Lipidol. 2004 Dec;15(6):637-43. Review.

PMID:
15529022
5.

Are Canadian guidelines for cholesterol lowering in high-risk patients optimal?

Fitchett DH, Leiter LA, Tardif JC, Goodman S, Langer A.

Can J Cardiol. 2005 Jan;21(1):85-90. Review.

PMID:
15685308
6.

Early time to benefit with intensive statin treatment: could it be the pleiotropic effects?

Ray KK, Cannon CP.

Am J Cardiol. 2005 Sep 5;96(5A):54F-60F. Review.

PMID:
16126024
7.

Atorvastatin: its clinical role in cerebrovascular prevention.

Gaspardone A, Arca M.

Drugs. 2007;67 Suppl 1:55-62. Review.

PMID:
17910521
8.

The next step in cardiovascular protection.

Cannon CP.

Atheroscler Suppl. 2003 Dec;4(5):3-9. Review.

PMID:
14980229
10.

Importance of intensive lipid lowering in acute coronary syndrome and percutaneous coronary intervention.

Kumar A, Cannon CP.

J Interv Cardiol. 2007 Dec;20(6):447-57. Review.

PMID:
18042049
12.

Atorvastatin: a pharmacoeconomic review of its use in the primary and secondary prevention of cardiovascular events.

Plosker GL, Lyseng-Williamson KA.

Pharmacoeconomics. 2007;25(12):1031-53. Review.

PMID:
18047388
13.

Effects of aggressive statin therapy on patients with coronary saphenous vein bypass grafts: a systematic review and meta-analysis of randomized, controlled trials.

Kang S, Liu Y, Liu XB.

Clin Ther. 2013 Aug;35(8):1125-36. doi: 10.1016/j.clinthera.2013.06.006. Epub 2013 Aug 7. Review.

PMID:
23932462
14.

[Statin treatment in patients with acute coronary syndrome].

Tani S.

Nihon Rinsho. 2006 Apr;64(4):755-61. Review. Japanese.

PMID:
16613195
15.

[Indications for statin therapy in patients with acute coronary syndrome of ischemic origin].

Raddino R, Della Pina P, Gorga E, Caretta G, Madureri A, Dei Cas L.

G Ital Cardiol (Rome). 2010 Oct;11(10 Suppl 1):78S-83S. Review. Italian.

PMID:
21416832
16.

Statins for acute coronary syndrome.

Vale N, Nordmann AJ, Schwartz GG, de Lemos J, Colivicchi F, den Hartog F, Ostadal P, Macin SM, Liem AH, Mills E, Bhatnagar N, Bucher HC, Briel M.

Cochrane Database Syst Rev. 2011 Jun 15;(6):CD006870. doi: 10.1002/14651858.CD006870.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;9:CD006870.

PMID:
21678362
17.

[High-dose statin therapy for high-risk patients].

Saely CH, Drexel H, Huber K.

Herz. 2010 Oct;35(7):497-502. doi: 10.1007/s00059-010-3381-8. Review. German.

PMID:
20941469
18.

Statin and the risk of renal-related serious adverse events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and other placebo-controlled trials.

Bangalore S, Fayyad R, Hovingh GK, Laskey R, Vogt L, DeMicco DA, Waters DD; Treating to New Targets Steering Committee and Investigators.

Am J Cardiol. 2014 Jun 15;113(12):2018-20. doi: 10.1016/j.amjcard.2014.03.046. Epub 2014 Apr 3. Review.

PMID:
24793673
20.

High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.

Koenig W.

Int J Cardiol. 2013 Oct 15;168(6):5126-34. doi: 10.1016/j.ijcard.2013.07.113. Epub 2013 Aug 24. Review.

PMID:
23978367
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk